JP2021527130A - 組織傷害および集中治療後症候群の処置および予防のためのハロゲン化合物の使用 - Google Patents

組織傷害および集中治療後症候群の処置および予防のためのハロゲン化合物の使用 Download PDF

Info

Publication number
JP2021527130A
JP2021527130A JP2021518059A JP2021518059A JP2021527130A JP 2021527130 A JP2021527130 A JP 2021527130A JP 2021518059 A JP2021518059 A JP 2021518059A JP 2021518059 A JP2021518059 A JP 2021518059A JP 2021527130 A JP2021527130 A JP 2021527130A
Authority
JP
Japan
Prior art keywords
iodide
subject
injury
certain embodiments
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021518059A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021527130A5 (https=
JPWO2019237065A5 (https=
Inventor
スティーブン エー． ヒル，
マーク ビー． ロス，
ジョン ダブリュー． ラングストン，
マイケル エル． モリソン，
岩田　明子
マイケル アンドリュー インスコ，
Original Assignee
ファラデイ ファーマシューティカルズ， インコーポレイテッド
フレッド ハッチンソン キャンサー リサーチ センター
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ファラデイ ファーマシューティカルズ， インコーポレイテッド, フレッド ハッチンソン キャンサー リサーチ センター filed Critical ファラデイ ファーマシューティカルズ， インコーポレイテッド
Publication of JP2021527130A publication Critical patent/JP2021527130A/ja
Publication of JP2021527130A5 publication Critical patent/JP2021527130A5/ja
Publication of JPWO2019237065A5 publication Critical patent/JPWO2019237065A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/18—Iodine; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Transplantation (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2021518059A 2018-06-08 2019-06-07 組織傷害および集中治療後症候群の処置および予防のためのハロゲン化合物の使用 Pending JP2021527130A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201862682574P 2018-06-08 2018-06-08
US62/682,574 2018-06-08
US201862730927P 2018-09-13 2018-09-13
US201862730945P 2018-09-13 2018-09-13
US62/730,945 2018-09-13
US62/730,927 2018-09-13
PCT/US2019/036154 WO2019237065A1 (en) 2018-06-08 2019-06-07 Use of halogen compounds for the treatment and prevention of tissue injury and post-intensive care syndrome

Publications (3)

Publication Number Publication Date
JP2021527130A true JP2021527130A (ja) 2021-10-11
JP2021527130A5 JP2021527130A5 (https=) 2022-05-13
JPWO2019237065A5 JPWO2019237065A5 (https=) 2022-05-13

Family

ID=68770655

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021518059A Pending JP2021527130A (ja) 2018-06-08 2019-06-07 組織傷害および集中治療後症候群の処置および予防のためのハロゲン化合物の使用

Country Status (10)

Country Link
US (1) US20210252047A1 (https=)
EP (1) EP3801565A4 (https=)
JP (1) JP2021527130A (https=)
KR (1) KR20210018898A (https=)
CN (1) CN112469422A (https=)
AU (1) AU2019282820A1 (https=)
CA (1) CA3102792A1 (https=)
IL (1) IL279221A (https=)
MX (1) MX2020013306A (https=)
WO (1) WO2019237065A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX386702B (es) 2014-02-10 2025-03-19 Fred Hutchinson Cancer Center Tratamiento con halogeno de ataque cardiaco y lesion isquemica.

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000006202A1 (en) * 1998-07-29 2000-02-10 Apa Praha, S.R.O. Virucide drug containing iodine
JP2009519312A (ja) * 2005-12-14 2009-05-14 ブリストル−マイヤーズ スクイブ カンパニー 抗菌組成物
JP2017507929A (ja) * 2014-02-10 2017-03-23 フレッド ハッチンソン キャンサー リサーチ センター 心臓発作及び虚血損傷のハロゲン治療

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6248335B1 (en) * 1997-10-29 2001-06-19 Symbollon Corporation Stabilized oral pharmaceutical composition containing iodide and iodate and method

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000006202A1 (en) * 1998-07-29 2000-02-10 Apa Praha, S.R.O. Virucide drug containing iodine
JP2009519312A (ja) * 2005-12-14 2009-05-14 ブリストル−マイヤーズ スクイブ カンパニー 抗菌組成物
JP2017507929A (ja) * 2014-02-10 2017-03-23 フレッド ハッチンソン キャンサー リサーチ センター 心臓発作及び虚血損傷のハロゲン治療

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
HISTORY OF CHANGES FOR STUDY: NCT03470441, JPN6023011459, 16 March 2018 (2018-03-16), ISSN: 0005172377 *
PLOS ONE, vol. 9, JPN6023011458, 2014, pages 112458, ISSN: 0005172378 *

Also Published As

Publication number Publication date
AU2019282820A1 (en) 2021-01-21
CA3102792A1 (en) 2019-12-12
KR20210018898A (ko) 2021-02-18
EP3801565A4 (en) 2022-04-06
EP3801565A1 (en) 2021-04-14
CN112469422A (zh) 2021-03-09
US20210252047A1 (en) 2021-08-19
MX2020013306A (es) 2021-05-12
WO2019237065A1 (en) 2019-12-12
IL279221A (en) 2021-01-31

Similar Documents

Publication Publication Date Title
US12016880B2 (en) Halogen treatment of heart attack and ischemic injury
JP7048576B2 (ja) 酸素化コレステロールサルフェート、並びにポリアルキレングリコール、カルボキシメチルセルロース、及びポリオキシルグリセリドのうち少なくとも１種を含む組成物
JP2005515996A5 (https=)
WO2018049184A1 (en) Suspensions and diluents for metronidazole and baclofen
JP2022065119A (ja) 薬の副作用、薬の副作用に関連する症状、および／または、治療に伴う副作用を予防および／または改善するための組成物
JP2021527130A (ja) 組織傷害および集中治療後症候群の処置および予防のためのハロゲン化合物の使用
JP2019502751A5 (https=)
WO2021257806A1 (en) Iodide for treatment of nonthyroidal illness syndrome
JP2025015727A (ja) ｐ－ボロノフェニルアラニンを含有する注射液剤
JP6950966B2 (ja) スガマデクス又はその薬理学的に許容される塩含有液剤及びその製造方法
RU2195937C1 (ru) Комбинированный противотуберкулезный препарат (ризобутол)
JP6856813B1 (ja) 亜鉛点滴静注用製剤
CN110237033A (zh) 一种2,4二硝基苯酚注射液及其制备方法和用途
JPH10114682A (ja) グルコマンナン配合持効性内服用薬剤
HK1231000A1 (en) Treatment of heart attack and ischemic injury with sodium iodide
HK1231000B (en) Treatment of heart attack and ischemic injury with sodium iodide
WO2016175042A1 (ja) マグネシウム化合物を有効成分として含有する医薬製剤

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220502

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20220502

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20230316

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20230323

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A712

Effective date: 20230412

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20231012